Plain-English translation of NCT05396872 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is designed to help veterans with advanced prostate cancer make better-informed decisions about precision oncology—a type of treatment planning based on genetic testing of their cancer. Researchers are studying how patients, caregivers, and doctors currently talk about these testing options, and then they're creating a helpful tool (called a decision support tool) to make these conversations clearer and less confusing. The goal is to help you feel more confident and informed when making choices about your care.
Many patients diagnosed with advanced prostate cancer feel unsure or overwhelmed when deciding whether to have genetic testing or pursue targeted therapies. This study exists to understand where these feelings of confusion happen and to create better tools that help patients, families, and doctors communicate more clearly about these important medical choices.
You likely qualify if…
You likely don't qualify if…
If you join, you will allow researchers to record one of your medical appointments with your doctor and then answer questions in interviews or focus groups about your experience. In the later stages of the study, you may receive access to a new decision-support tool (available online, in print, or both) about genetic testing, and you'll be asked for your feedback on whether it was helpful. The whole process involves surveys and interviews spread over several weeks, with no expensive procedures or medications required.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
United States